dacarbazine has been researched along with Stomatitis, Vesicular in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, X; He, W; Huang, D; Jiang, B; Lun, X; Wang, Y; Wang, Z; Yin, X | 1 |
1 other study(ies) available for dacarbazine and Stomatitis, Vesicular
| Article | Year |
|---|---|
Temozolomide resistant human brain tumor stem cells are susceptible to recombinant vesicular stomatitis virus and double-deleted Vaccinia virus in vitro.
Topics: Brain Neoplasms; Cell Death; Cell Differentiation; Cell Self Renewal; Dacarbazine; Drug Resistance, Neoplasm; Humans; Neoplastic Stem Cells; Recombination, Genetic; Temozolomide; Vaccinia virus; Vesicular Stomatitis; Virus Replication | 2017 |